• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Express Scripts

Express Scripts

Express Scripts ESRX 4 Star

Last Price$74.72Day Change (%)-0.48%
Open Price$75.14Day Change ($)-0.36
Day Range74.48–75.4252-Week Range59.20–79.37

As of Wed 08/27/2014 03:37 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. A Rare, Wide-Moat Find in a Market With Few Values

    Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.

  2. WellPoint Reports Second Quarter 2014 Results

    WellPoint Reports Second Quarter 2014 Results

  3. Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point

    Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point

  4. A Few Picks to Tide Over the Bargain-Hunters

    In a fully valued market, there are worse things than buying wide-moat names at decent discounts.

  5. Morningstar Minute: 3 Pillars to Express Scripts' Wide Moat

    Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.

  6. Market Overreaction Makes Express Scripts Even More Attractive

    Misunderstanding on private health insurance exchanges could mean opportunity for investors.

  7. Fixed Income Roadmap: Where Next For Bonds?

    Express Scripts ESRX reported first-quarter results that beat our expectations. The company also increased its earnings-per-share guidance for the year, but more importantly to us, Express Scripts expects higher cash flow from operations in 2007 than it did previously. We're reviewing our model in ...

  8. UPDATE: Updates, advisories and surprises

    UPDATE: Updates, advisories and surprises

  9. UPDATE: Updates, advisories and surprises

    UPDATE: Updates, advisories and surprises

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.